Viking Global Investors Lp

Insider Reports History

Entity
Company
Location
600 Washington Blvd., Floor 11, Stamford, Connecticut
Signature
/s/ Scott M. Hendler signing on behalf of O. Andreas Halvorsen (7) (8)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Viking Global Investors Lp:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Pharma, Inc. 10%+ Owner Common Stock 25.1 M $954 M $37.97 Jul 18, 2023 Indirect
Roivant Sciences Ltd. 10%+ Owner Common Shares 12.9 M $133 M $10.35 Jun 22, 2023 Indirect
FIGS, Inc. 10%+ Owner Class A Common Stock 14.7 M $89.6 M $6.08 Sep 3, 2021 Indirect
Ginkgo Bioworks Holdings, Inc. 10%+ Owner Class A Common Stock 51.1 M $79.4 M $1.56 Mar 2, 2022 Indirect
4D Molecular Therapeutics, Inc. 10%+ Owner Common Stock 4.25 M $78.2 M $18.41 Jan 4, 2024 Indirect
STANDARD BIOTOOLS INC. 10%+ Owner Common Stock 19.4 M $53.2 M $2.75 Mar 18, 2024 Indirect
Amylyx Pharmaceuticals, Inc. 10%+ Owner Common Stock 1.85 M $30.2 M $16.33 Sep 9, 2022 Indirect
Rallybio Corp 10%+ Owner Pre-Funded Warrants to Purchase Common Stock 3.33 M $20 M $6.00 Nov 15, 2022 Indirect
PROCEPT BioRobotics Corp 10%+ Owner Common Stock 298 K $13.4 M $44.97 Mar 18, 2022 Indirect
Frazier Lifesciences Acquisition Corp 10%+ Owner Common Stock 1.21 M $12.2 M $10.08 Nov 2, 2022 Indirect
APi Group Corp 10%+ Owner Common Stock 0 $0 $38.15 Jun 17, 2024 Indirect
Inhibrx, Inc. 10%+ Owner Common Stock 0 $0 $30.00 May 30, 2024 Indirect
Inhibrx, Inc. 10%+ Owner Warrants (right to buy) 0 $0 $30.00 May 30, 2024 Indirect
RayzeBio, Inc. 10%+ Owner Common Stock 0 $0 $62.50 Feb 26, 2024 Indirect
Ginkgo Bioworks Holdings, Inc. 10%+ Owner Class C Common Stock 288 M Mar 2, 2022 Indirect
Inhibrx Biosciences, Inc. 10%+ Owner Common Stock 128 K May 29, 2024 Indirect
Amylyx Pharmaceuticals, Inc. 10%+ Owner Series C-1 Preferred Stock 0 Nov 11, 2022 Indirect
APi Group Corp 10%+ Owner 5.5% Series B Perpetual Convertible Preferred Stock 0 Feb 28, 2024 Indirect
Frazier Lifesciences Acquisition Corp 10%+ Owner Class A Ordinary Shares 0 Nov 22, 2022 Indirect
PROCEPT BioRobotics Corp 10%+ Owner Series E Preferred Stock 0 Sep 17, 2021 Indirect
PROCEPT BioRobotics Corp 10%+ Owner Series F Preferred Stock 0 Sep 17, 2021 Indirect
PROCEPT BioRobotics Corp 10%+ Owner Series G Preferred Stock 0 Sep 17, 2021 Indirect
RayzeBio, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Sep 19, 2023 Indirect
RayzeBio, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 Sep 19, 2023 Indirect
RayzeBio, Inc. 10%+ Owner Series D Convertible Preferred Stock 0 Sep 19, 2023 Indirect

Insider Reports Filed by Viking Global Investors Lp

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APG APi Group Corp Jun 17, 2024 2 -$74.5 M 4 Jun 18, 2024 10%+ Owner
APG APi Group Corp Jun 17, 2024 2 -$74.5 M 4 Jun 18, 2024 10%+ Owner
INBX Inhibrx, Inc. May 30, 2024 4 -$246 M 4 Jun 3, 2024 10%+ Owner
INXB Inhibrx Biosciences, Inc. May 29, 2024 0 $0 3 Jun 7, 2024 10%+ Owner
LAB STANDARD BIOTOOLS INC. Mar 18, 2024 0 $0 3 Mar 20, 2024 10%+ Owner
APG APi Group Corp Mar 5, 2024 2 -$104 M 4 Mar 7, 2024 10%+ Owner
APG APi Group Corp Mar 5, 2024 2 -$104 M 4 Mar 7, 2024 10%+ Owner
APG APi Group Corp Feb 28, 2024 6 $51.7 M 4 Mar 1, 2024 10%+ Owner
APG APi Group Corp Feb 28, 2024 6 $51.7 M 4 Mar 1, 2024 10%+ Owner
RYZB RayzeBio, Inc. Feb 26, 2024 2 $0 4 Feb 28, 2024 10%+ Owner
RYZB RayzeBio, Inc. Feb 26, 2024 2 $0 4 Feb 28, 2024 10%+ Owner
FDMT 4D Molecular Therapeutics, Inc. Jan 4, 2024 1 -$10.5 M 4 Jan 5, 2024 10%+ Owner
APG APi Group Corp Jan 2, 2024 3 -$203 M 4 Jan 4, 2024 10%+ Owner
APG APi Group Corp Jan 2, 2024 3 -$203 M 4 Jan 4, 2024 10%+ Owner
RYZB RayzeBio, Inc. Sep 19, 2023 10 $25 M 4 Sep 21, 2023 10%+ Owner
RYZB RayzeBio, Inc. Sep 19, 2023 10 $25 M 4 Sep 21, 2023 10%+ Owner
RYZB RayzeBio, Inc. Sep 14, 2023 0 $0 3 Sep 14, 2023 10%+ Owner
RYZB RayzeBio, Inc. Sep 14, 2023 0 $0 3 Sep 14, 2023 10%+ Owner
INBX Inhibrx, Inc. Aug 28, 2023 2 $30 M 4 Aug 30, 2023 10%+ Owner
BBIO BridgeBio Pharma, Inc. Jul 18, 2023 1 -$52.5 M 4 Jul 19, 2023 10%+ Owner
ROIV Roivant Sciences Ltd. Jun 22, 2023 4 -$129 M 4 Jun 26, 2023 10%+ Owner
FDMT 4D Molecular Therapeutics, Inc. May 9, 2023 1 $13.6 M 4 May 11, 2023 10%+ Owner
FLAC Frazier Lifesciences Acquisition Corp Nov 22, 2022 2 $0 4 Nov 25, 2022 10%+ Owner
RLYB Rallybio Corp Nov 15, 2022 1 $20 M 4 Nov 17, 2022 10%+ Owner
FLAC Frazier Lifesciences Acquisition Corp Nov 2, 2022 2 $8.54 M 4 Nov 4, 2022 10%+ Owner
FLAC Frazier Lifesciences Acquisition Corp Nov 1, 2022 0 $0 3 Nov 4, 2022 10%+ Owner
INBX Inhibrx, Inc. Oct 7, 2022 2 $40 M 4 Oct 12, 2022 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Sep 8, 2022 16 -$41.7 M 4 Sep 9, 2022 10%+ Owner
PRCT PROCEPT BioRobotics Corp Mar 18, 2022 2 -$37.3 M 4 Mar 22, 2022 10%+ Owner
DNA Ginkgo Bioworks Holdings, Inc. Mar 2, 2022 2 $0 4 Mar 4, 2022 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Jan 11, 2022 3 $43.7 M 4 Jan 13, 2022 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2022 0 $0 3 Jan 11, 2022 10%+ Owner
APG APi Group Corp Jan 3, 2022 2 $200 M 4 Jan 5, 2022 10%+ Owner
ROIV Roivant Sciences Ltd. Oct 1, 2021 0 $0 3 Oct 1, 2021 10%+ Owner
PRCT PROCEPT BioRobotics Corp Sep 17, 2021 7 $14 M 4 Sep 21, 2021 10%+ Owner
DNA Ginkgo Bioworks Holdings, Inc. Sep 16, 2021 0 $0 3 Sep 23, 2021 10%+ Owner
PRCT PROCEPT BioRobotics Corp Sep 14, 2021 0 $0 3 Sep 14, 2021 10%+ Owner
FIGS FIGS, Inc. Sep 2, 2021 2 -$9.36 M 4 Sep 3, 2021 10%+ Owner
RLYB Rallybio Corp Jul 29, 2021 3 $10.5 M 4 Aug 2, 2021 10%+ Owner
RLYB Rallybio Corp Jul 29, 2021 0 $0 3 Jul 29, 2021 10%+ Owner
FIGS FIGS, Inc. May 26, 2021 0 $0 3 Jun 7, 2021 10%+ Owner